In CML-BP lymphoid phenotype, individualization of the induction intensity can be achieved with parallel monitoring of clone-specific IgH/TCR rearrangement markers and BCR::ABL1 transcripts. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.